rythmodan 100 mg, capsules
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - disopyramide - capsule - disopyramide 100 mg - cardiac therapy
rythmodan 100mg milligram capsule
hoechst marion roussel irl ltd - disopyramide phosphate - capsule - 100mg milligram
rythmodan 150mg milligram capsule
hoechst marion roussel irl ltd - disopyramide phosphate - capsule - 150mg milligram
diso durules
astrazeneca limited - disopyramide phosphate 193.2mg equivalent to 150 mg disopyramide base - modified release tablet - 150 mg - active: disopyramide phosphate 193.2mg equivalent to 150 mg disopyramide base excipient: carbomer ethanol hard paraffin hydrogen peroxide hypromellose macrogol 6000 magnesium stearate polyvinyl acetate purified water titanium dioxide
rythmodan retard
sanofi-aventis new zealand limited - disopyramide phosphate 322.5mg equivalent to 250 mg disopyramide base - modified release tablet - 250 mg - active: disopyramide phosphate 322.5mg equivalent to 250 mg disopyramide base excipient: glyceryl monostearate hypromellose magnesium stearate povidone propylene glycol sorbitan laurate sucrose titanium dioxide
norpace
pharmacia limited company trading as pharmacia - disopyramide phosphate 100mg (and 150mg) - capsule - 100mg, 150mg - active: disopyramide phosphate 100mg (and 150mg)
norpace
pharmacia limited company trading as pharmacia - disopyramide phosphate 20 mg/ml - solution for injection - 100mg/5ml,200mg/10ml - active: disopyramide phosphate 20 mg/ml
norpace retard
pharmacia limited company trading as pharmacia - disopyramide phosphate 193.2mg; ; - modified release tablet - 150 mg - active: disopyramide phosphate 193.2mg
rythmodan
sanofi-aventis new zealand limited - disopyramide phosphate 10 mg/ml - solution for injection - 50mg/5ml - active: disopyramide phosphate 10 mg/ml
rythmodan solution for injection 10 mg/ml
roussel laboratories limited - disopyramide phosphate - solution for injection - 10 mg/ml